| Target and Pathway |
Top |
| Target(s) |
Angiogenesis (AGG) |
Target Info
|
Inhibitor |
[1] |
| DNA topoisomerase I (TOP1) |
Target Info
|
Modulator |
[2] |
| Hepatocyte growth factor (HGF) |
Target Info
|
Inhibitor |
[1] |
| Tubulin beta (TUBB) |
Target Info
|
Modulator |
[2] |
| Vascular endothelial growth factor A (VEGFA) |
Target Info
|
Inhibitor |
[1] |
|
KEGG Pathway
|
Phagosome
|
|
Gap junction
|
|
Pathogenic Escherichia coli infection
|
|
Ras signaling pathway
|
|
Rap1 signaling pathway
|
|
Cytokine-cytokine receptor interaction
|
|
HIF-1 signaling pathway
|
|
mTOR signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
VEGF signaling pathway
|
|
Focal adhesion
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
MicroRNAs in cancer
|
|
Renal cell carcinoma
|
|
Pancreatic cancer
|
|
Bladder cancer
|
|
Rheumatoid arthritis
|
|
Malaria
|
|
Melanoma
|
|
NetPath Pathway
|
IL2 Signaling Pathway
|
|
FSH Signaling Pathway
|
|
TCR Signaling Pathway
|
|
EGFR1 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
TSH Signaling Pathway
|
|
Leptin Signaling Pathway
|
|
TNFalpha Signaling Pathway
|
|
Panther Pathway
|
DNA replication
|
|
Cytoskeletal regulation by Rho GTPase
|
|
Huntington disease
|
|
Angiogenesis
|
|
VEGF signaling pathway
|
|
Pathway Interaction Database
|
Caspase Cascade in Apoptosis
|
|
Glypican 1 network
|
|
HIF-2-alpha transcription factor network
|
|
Beta3 integrin cell surface interactions
|
|
S1P3 pathway
|
|
Signaling events mediated by TCPTP
|
|
S1P1 pathway
|
|
Alpha9 beta1 integrin signaling events
|
|
Integrins in angiogenesis
|
|
VEGFR1 specific signals
|
|
HIF-1-alpha transcription factor network
|
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
|
Arf6 signaling events
|
|
Direct p53 effectors
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
Syndecan-1-mediated signaling events
|
|
Stabilization and expansion of the E-cadherin adherens junction
|
|
FGF signaling pathway
|
|
Reactome
|
Regulation of PLK1 Activity at G2/M Transition
|
|
Loss of Nlp from mitotic centrosomes
|
|
Recruitment of mitotic centrosome proteins and complexes
|
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
|
Anchoring of the basal body to the plasma membrane
|
|
Platelet degranulation
|
|
Regulation of gene expression by Hypoxia-inducible Factor
|
|
VEGF ligand-receptor interactions
|
|
VEGF binds to VEGFR leading to receptor dimerization
|
|
Interleukin-7 signaling
|
|
WikiPathways
|
Integrated Pancreatic Cancer Pathway
|
|
Parkin-Ubiquitin Proteasomal System pathway
|
|
Pathogenic Escherichia coli infection
|
|
Mitotic G2-G2/M phases
|
|
SIDS Susceptibility Pathways
|
|
Hypertrophy Model
|
|
Endochondral Ossification
|
|
Focal Adhesion
|
|
Differentiation Pathway
|
|
Bladder Cancer
|
|
Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
|
|
Nifedipine Activity
|
|
Aryl Hydrocarbon Receptor
|
|
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
|
|
Oncostatin M Signaling Pathway
|
|
Allograft Rejection
|
|
Integrated Breast Cancer Pathway
|
|
Signaling by VEGF
|
|
Heart Development
|
|
Angiogenesis
|
|
Signaling of Hepatocyte Growth Factor Receptor
|
|
NRF2 pathway
|
|
Nuclear Receptors Meta-Pathway
|
|
Extracellular vesicle-mediated signaling in recipient cells
|
|
Interleukin-7 signaling
|
|
Prostate Cancer
|
